Pharmapack Podcast: The opportunities and challenges of bringing connected devices to market in the drug delivery sector
Smart, connected devices are revolutionizing drug delivery in the ways they can gather, order and transmit crucial patient data to physicians
Connected smart devices have transformed everyday life in many ways over the last few years. This is particularly evident in the consumer space, where on top of the ‘must-have’ smartphones, computers and wearables, there are now also solutions for recharging, home lighting, managing appliances and energy saving.
However, when it comes to connected drug delivery, the ecosystem is undoubtedly much more complex, not least because it operates in a highly regulated environment. Also, healthcare systems around the world can differ greatly, in terms of clinical practice, pricing and competition and can also be subject to sudden changes brought on by new governmental policy or funding.
Taking all this into account, it is nevertheless an extremely exciting time for product innovators in the drug delivery sector. Digital technology has to all intents and purposes been a real game changer and companies working in this space are finely balancing the opportunity that harnessing the power of this technology can present with the pressing challenge of addressing unmet needs such as patient adherence and compliance.
In this interview with Eric Dessertenne, CEO of BIOCORP and Sebastien Ferrandon, Global Head of Diabetes Integrated Care at Sanofi, we discuss the potential of connected devices, where we are in their story arc and where the future growth opportunities really lie.
Click the link below to listen to the podcast:
Related News
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines. -
News Women in Pharma: Manufacturing personal and team success
Our monthly Women in Pharma series highlights the influential lives and works of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive... -
News Pfizer may shift production back to US under Trump pharma tariffs
At the 45th TD Cowen annual healthcare conference in Boston, USA, Pfizer CEO Albert Bourla outlined the potential for Pfizer to shift its overseas drug manufacturing back to the US as pharmaceutical industry players weigh their options against Presiden... -
News Experimental drug for managing aortic valve stenosis shows promise
The new small molecule drug ataciguat is garnering attention for its potential to manage aortic valve stenosis, which may prevent the need for surgery and significantly improve patient experience. -
News Women in Pharma: Connecting accessible pharma packaging to patients – a Pharmapack Special
Throughout our Women in Pharma series, we aim to highlight how CPHI events encourage discussions around diversity, equity, and inclusion initiatives in the pharmaceutical industry. -
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries. -
News Trump administration halts global supply of HIV, malaria, tuberculosis drugs
In various memos circulated to the United States Agency for International Development (USAID), the Trump administration has demanded contractors and partners to immediately stop work in supplying lifesaving drugs for HIV, malaria, and tuberculosis to c... -
News 2024 Drug Approvals: a lexicon of notable drugs and clinical trials
50 drugs received FDA approval in 2024. The centre for biologics evaluation and research also identified six new Orphan drug approvals as under Biologics License Applications (BLAs). The following list picks out key approvals from the list, and highlig...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance